Fred Schobben

683 total citations
14 papers, 524 citations indexed

About

Fred Schobben is a scholar working on Pediatrics, Perinatology and Child Health, Psychiatry and Mental health and Pharmacology. According to data from OpenAlex, Fred Schobben has authored 14 papers receiving a total of 524 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pediatrics, Perinatology and Child Health, 4 papers in Psychiatry and Mental health and 3 papers in Pharmacology. Recurrent topics in Fred Schobben's work include Pharmacological Effects and Toxicity Studies (5 papers), Epilepsy research and treatment (4 papers) and Antibiotics Pharmacokinetics and Efficacy (3 papers). Fred Schobben is often cited by papers focused on Pharmacological Effects and Toxicity Studies (5 papers), Epilepsy research and treatment (4 papers) and Antibiotics Pharmacokinetics and Efficacy (3 papers). Fred Schobben collaborates with scholars based in Netherlands, Armenia and Belgium. Fred Schobben's co-authors include Eppo van der Kleijn, F.J.M. Gabreëls, Gerard H. A. Visser, Tessa Ververs, Lolkje de Jong‐van den Berg, Toine C. G. Egberts, Tom B. Vree, F.W.H.M. Merkus, Wilfried Gyselaers and Johannes J. Duvekot and has published in prestigious journals such as Neurology, The American Journal of Cardiology and Journal of Chromatography A.

In The Last Decade

Fred Schobben

14 papers receiving 482 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fred Schobben Netherlands 8 215 187 120 89 70 14 524
Jochen G.W. Theis Canada 11 292 1.4× 365 2.0× 110 0.9× 61 0.7× 38 0.5× 19 677
Júlia Ojuel Spain 14 329 1.5× 313 1.7× 30 0.3× 97 1.1× 17 0.2× 23 768
Rose Maxwell United States 15 299 1.4× 260 1.4× 31 0.3× 92 1.0× 109 1.6× 55 758
Gerhard Luef Austria 15 463 2.2× 284 1.5× 422 3.5× 120 1.3× 19 0.3× 41 819
Élisabeth Frauger France 21 122 0.6× 616 3.3× 186 1.6× 323 3.6× 94 1.3× 71 1.2k
R Olegård Sweden 17 742 3.5× 111 0.6× 49 0.4× 71 0.8× 125 1.8× 40 1.1k
Nicole Fischer United States 12 71 0.3× 88 0.5× 31 0.3× 61 0.7× 58 0.8× 26 488
David C. Abramson United States 14 103 0.5× 36 0.2× 40 0.3× 49 0.6× 76 1.1× 23 565
Daniel B. Williams United States 15 104 0.5× 194 1.0× 17 0.1× 57 0.6× 41 0.6× 35 703
Carl Zelson United States 8 417 1.9× 129 0.7× 21 0.2× 28 0.3× 57 0.8× 10 539

Countries citing papers authored by Fred Schobben

Since Specialization
Citations

This map shows the geographic impact of Fred Schobben's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fred Schobben with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fred Schobben more than expected).

Fields of papers citing papers by Fred Schobben

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fred Schobben. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fred Schobben. The network helps show where Fred Schobben may publish in the future.

Co-authorship network of co-authors of Fred Schobben

This figure shows the co-authorship network connecting the top 25 collaborators of Fred Schobben. A scholar is included among the top collaborators of Fred Schobben based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fred Schobben. Fred Schobben is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Heus, Roel de, Ben W. Mol, J.J.H.M. Erwich, et al.. (2009). Adverse drug reactions to tocolytic treatment for preterm labour: prospective cohort study. BMJ. 338(mar05 2). b744–b744. 84 indexed citations
2.
Ververs, Tessa, et al.. (2009). Depression during pregnancy: views on antidepressant use and information sources of general practitioners and pharmacists. BMC Health Services Research. 9(1). 119–119. 24 indexed citations
3.
Niermeijer, J.M.F., M. Eurelings, Michiel W. van der Linden, et al.. (2007). Intermittent cyclophosphamide with prednisone versus placebo for polyneuropathy with IgM monoclonal gammopathy. Neurology. 69(1). 50–59. 41 indexed citations
4.
Ververs, Tessa, et al.. (2006). Prevalence and patterns of antidepressant drug use during pregnancy. European Journal of Clinical Pharmacology. 62(10). 863–870. 147 indexed citations
5.
Schobben, Fred, Yechiel A. Hekster, & Barbara van Zwieten‐Boot. (1997). Outcome measures for the assessment of new antiepileptic drugs.. Pharmacy World & Science. 19(5). 223–226. 3 indexed citations
6.
Smit, Johannes W. A., et al.. (1995). Effects of alcohol consumption on pharmacokinetics, efficacy, and safety of fluvastatin. The American Journal of Cardiology. 76(1-2). 89A–96A. 17 indexed citations
7.
Schobben, Fred. (1988). Optimal dosing of aminoglycosides using computerised models.. PubMed. 57. 54–7. 1 indexed citations
8.
Schobben, Fred, et al.. (1983). Clinical pharmacokinetics and therapeutic application of antiepileptic drugs.. PubMed. 61. 143–69. 2 indexed citations
9.
Kleijn, Eppo van der, et al.. (1983). Continuous monitoring of plasma antiepileptic drug levels. Acta Neurologica Scandinavica. 68. 91–114. 3 indexed citations
10.
Schobben, Fred, Eppo van der Kleijn, & Tom B. Vree. (1980). Therapeutic Monitoring of Valproic Acid. Therapeutic Drug Monitoring. 2(1). 61–72. 34 indexed citations
11.
Kleijn, Eppo van der, Fred Schobben, & T. B. Vree. (1980). Clinical Pharmacokinetics of Antiepileptic Drugs. Drug Intelligence & Clinical Pharmacy. 14(10). 674–685. 7 indexed citations
12.
Schobben, Fred & Eppo van der Kleijn. (1977). Drug determinations in body fluids by the enzyme multiplied immunoassay technique (EMIT®). European Journal of Drug Metabolism and Pharmacokinetics. 2(4). 185–189. 4 indexed citations
13.
Schobben, Fred, Eppo van der Kleijn, & F.J.M. Gabreëls. (1975). Pharmacokinetics of di-n-propylacetate in epileptic patients. European Journal of Clinical Pharmacology. 8(2). 97–105. 125 indexed citations
14.
Merkus, F.W.H.M., et al.. (1975). Rapid gas chromatographic determination of disopyamide in serum using a nitrogen detector. Journal of Chromatography A. 109(2). 432–435. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026